Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorTongji Hospital

About this trial

In light of the ongoing controversy surrounding the efficacy of bupivacaine liposomes, our study was designed to investigate, for the first time, the differential postoperative analgesic effects between bupivacaine liposomes combined with bupivacaine hydrochloride and bupivacaine hydrochloride alone in transverse thoracic muscle plane block treatment. The aim is to provide evidence-based medical guidance for drug selection in regional block local anesthesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-90 years;

ASA Class I ~ III;

Patients undergoing elective median sternotomy.

Disqualifiers

Emergency surgery;

Re-operation;

Coagulation dysfunction;

Preoperative left ventricular function was poor (ejection fraction <35%);

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transverse thoracic muscle plane block (TTMPB) using liposomal bupivacaine and bupivacaine mixture

    Procedure/Surgery

    Liposomal bupivacaine and bupivacaine mixture were used for transverse thoracic muscle plane block (TTMPB) in experimental group.

  • Transverse thoracic muscle plane block (TTMPB) using bupivacaine hydrochloride

    Procedure/Surgery

    Bupivacaine hydrochloride was used for transverse thoracic muscle plane block (TTMPB) in active control group.

Treatment groups

38 Participants
are divided into 2 treatment groups
Group A: Mixture of liposome bupivacaine and bupivacaine hydrochlorideExperimental treatment 1 intervention
Group B: Bupivacaine hydrochloride aloneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Third-day opioid consumption

Opioid consumption was converted to Milligram morphine equivalent (MME) using the analgesic Drug Equivalence calculator.

Time frame
48-72 hours after surgery

Secondary outcomes

1

Cumulative opioid consumption 72 hours after surgery

Opioid consumption was converted to Milligram morphine equivalent (MME) using the analgesic Drug Equivalence calculator.

Time frame
0-72 hours after surgery
2

Numerical rating scales, NRS

Numerical rating scales, NRS: 0-10 A score of 0 is reported as completely painless, and a score of 10 is reported as the most intolerable pain.

Time frame
24 hours, 48 hours and 72 hours after surgery
3

Sensory block resolution time

Time of resolution of numbness in the sternum skin.

Time frame
0-72 hours after surgery
4

Consumption of acetaminophen

Acetaminophen requirement after surgery.

Time frame
0-72 hours after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.